Additional preferred-equity offering · Healthtech

Gradient Health discloses $2.13 million preferred-equity offering

An October SEC notice reports a fully sold offering to one unnamed investor, separate from the company's earlier $3 million notice.

Gradient Health disclosed $2,132,720 in preferred-equity sales in a Form D filed on October 7, 2026. The Durham medical-data company reported the same amount as its total offering, with one investor and no remaining securities to sell under the notice.

The filing dates the first sale to October 6 and describes preferred shares together with the underlying capital stock into which they may convert. That conversion feature is part of an equity security, rather than a disclosure of convertible debt.

Gradient's earlier 2026 notice reported a separate $3 million offering with an August 13 first sale. The October document is a new notice with its own first-sale date and sold amount; this article reports that offering rather than combining the two into a single August financing. Neither notice names the subscriber or specifies a venture-round stage.

Gradient Health supplies curated, de-identified medical datasets to AI developers and research teams. Its Atlas platform connects healthcare-data partners with customers seeking patient records for model development and validation.

Funding history

Additional preferred-equity offering · This round$2.1M

Sources

  1. Gradient Health October preferred-stock offeringsec.gov · Oct 7, 2026
  2. sec.gov
  3. Gradient Health separate earlier offeringsec.gov
  4. Gradient Health official data platformgradienthealth.io